KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2016 - 2026)

Gilead Sciences filings provide 17 years of Accumulated Depreciation & Amortization readings, the most recent being $2.7 billion for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 9.15% to $2.7 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 billion, a 9.15% increase, with the full-year FY2025 number at $2.7 billion, up 9.15% from a year prior.
  • Accumulated Depreciation & Amortization hit $2.7 billion in Q4 2025 for Gilead Sciences, roughly flat from $2.7 billion in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $2.7 billion in Q4 2025 to a low of $1.9 billion in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $2.5 billion (2024), compared with a mean of $2.4 billion.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 15.48% in 2022 and later rose 0.86% in 2024.
  • Gilead Sciences' Accumulated Depreciation & Amortization stood at $1.9 billion in 2021, then rose by 15.48% to $2.2 billion in 2022, then increased by 12.03% to $2.4 billion in 2023, then rose by 0.86% to $2.5 billion in 2024, then rose by 9.15% to $2.7 billion in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $2.7 billion (Q4 2025), $2.7 billion (Q3 2025), and $2.6 billion (Q2 2025) per Business Quant data.